Abstract
We thank Drs. Bryant and Protas for the comment on our article,1 and for pointing out their supportive study.2 Together, our data suggest that underutilization of rehabilitation therapies in Parkinson disease (PD) is persistent and pervasive. During the time period of these 2 studies, several randomized controlled trials were published that supported the use of rehabilitation therapies in PD.3,4 Improvements in mobility, activities of daily living, speech volume, and quality of life were demonstrated in these and other studies. This is another example of the gap between PD research and implementation. The barriers to dissemination of proven treatments need to be addressed for PD outcomes to improve.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
